<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="TrEMBL" created="2001-06-01" modified="2015-01-07" version="73">
<accession>Q9BH77</accession>
<name>Q9BH77_PLAFA</name>
<protein>
<submittedName>
<fullName evidence="9">Enoyl-ACP reductase</fullName>
</submittedName>
<submittedName>
<fullName evidence="8">Enoyl-acyl carrier reductase</fullName>
</submittedName>
</protein>
<gene>
<name type="primary" evidence="9">FabI</name>
</gene>
<organism evidence="8">
<name type="scientific">Plasmodium falciparum</name>
<dbReference type="NCBI Taxonomy" id="5833"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Alveolata</taxon>
<taxon>Apicomplexa</taxon>
<taxon>Aconoidasida</taxon>
<taxon>Haemosporida</taxon>
<taxon>Plasmodium</taxon>
<taxon>Plasmodium (Laverania)</taxon>
</lineage>
</organism>
<reference key="1" evidence="8">
<citation type="journal article" date="2001" name="Int. J. Parasitol." volume="31" first="109" last="113">
<title>Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.</title>
<authorList>
<person name="McLeod R."/>
<person name="Muench S.P."/>
<person name="Rafferty J.B."/>
<person name="Kyle D.E."/>
<person name="Mui E.J."/>
<person name="Kirisits M.J."/>
<person name="Mack D.G."/>
<person name="Roberts C.W."/>
<person name="Samuel B.U."/>
<person name="Lyons R.E."/>
<person name="Dorris M."/>
<person name="Milhous W.K."/>
<person name="Rice D.W."/>
</authorList>
<dbReference type="PubMed" id="11239932"/>
<dbReference type="DOI" id="10.1016/S0020-7519(01)00111-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE</scope>
</reference>
<reference key="2" evidence="9">
<citation type="journal article" date="2001" name="Nat. Med." volume="7" first="167" last="173">
<title>Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.</title>
<authorList>
<person name="Surolia N."/>
<person name="Surolia A."/>
</authorList>
<dbReference type="PubMed" id="11175846"/>
<dbReference type="DOI" id="10.1038/84612"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE</scope>
</reference>
<reference key="3" evidence="1 2 3">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="13106" last="13114">
<title>Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.</title>
<authorList>
<person name="Perozzo R."/>
<person name="Kuo M."/>
<person name="Sidhu A.b."/>
<person name="Valiyaveettil J.T."/>
<person name="Bittman R."/>
<person name="Jacobs W.R."/>
<person name="Fidock D.A."/>
<person name="Sacchettini J.C."/>
</authorList>
<dbReference type="PubMed" id="11792710"/>
<dbReference type="DOI" id="10.1074/jbc.M112000200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 97-325 AND 366-425 IN COMPLEX WITH NAD</scope>
</reference>
<reference key="4" evidence="4">
<citation type="journal article" date="2005" name="Bioorg. Med. Chem. Lett." volume="15" first="5247" last="5252">
<title>Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.</title>
<authorList>
<person name="Freundlich J.S."/>
<person name="Anderson J.W."/>
<person name="Sarantakis D."/>
<person name="Shieh H.M."/>
<person name="Yu M."/>
<person name="Valderramos J.C."/>
<person name="Lucumi E."/>
<person name="Kuo M."/>
<person name="Jacobs W.R."/>
<person name="Fidock D.A."/>
<person name="Schiehser G.A."/>
<person name="Jacobus D.P."/>
<person name="Sacchettini J.C."/>
</authorList>
<dbReference type="PubMed" id="16198563"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2005.08.044"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 97-432 IN COMPLEX WITH NAD</scope>
</reference>
<reference key="5" evidence="5 6 7">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="25436" last="25444">
<title>X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy.</title>
<authorList>
<person name="Freundlich J.S."/>
<person name="Wang F."/>
<person name="Tsai H.C."/>
<person name="Kuo M."/>
<person name="Shieh H.M."/>
<person name="Anderson J.W."/>
<person name="Nkrumah L.J."/>
<person name="Valderramos J.C."/>
<person name="Yu M."/>
<person name="Kumar T.R."/>
<person name="Valderramos S.G."/>
<person name="Jacobs W.R."/>
<person name="Schiehser G.A."/>
<person name="Jacobus D.P."/>
<person name="Fidock D.A."/>
<person name="Sacchettini J.C."/>
</authorList>
<dbReference type="PubMed" id="17567585"/>
<dbReference type="DOI" id="10.1074/jbc.M701813200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 366-425 IN COMPLEX WITH NAD</scope>
</reference>
<dbReference type="EMBL" id="AF338731">
<property type="protein sequence ID" value="AAK25802.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF332608">
<property type="protein sequence ID" value="AAK38273.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PDB" id="1NHG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="A/B=97-325, C/D=366-425"/>
</dbReference>
<dbReference type="PDB" id="1NHW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=97-325, C/D=366-425"/>
</dbReference>
<dbReference type="PDB" id="1NNU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=97-325, C/D=366-425"/>
</dbReference>
<dbReference type="PDB" id="1VRW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=97-432"/>
</dbReference>
<dbReference type="PDB" id="1ZW1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=97-432"/>
</dbReference>
<dbReference type="PDB" id="2NQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C/D=366-425"/>
</dbReference>
<dbReference type="PDB" id="2OP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=96-425"/>
</dbReference>
<dbReference type="PDB" id="2OP1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=96-425"/>
</dbReference>
<dbReference type="PDBsum" id="1NHG"/>
<dbReference type="PDBsum" id="1NHW"/>
<dbReference type="PDBsum" id="1NNU"/>
<dbReference type="PDBsum" id="1VRW"/>
<dbReference type="PDBsum" id="1ZW1"/>
<dbReference type="PDBsum" id="2NQ8"/>
<dbReference type="PDBsum" id="2OP0"/>
<dbReference type="PDBsum" id="2OP1"/>
<dbReference type="SMR" id="Q9BH77">
<property type="residue range" value="96-429"/>
</dbReference>
<dbReference type="BRENDA" id="1.3.1.9">
<property type="organism ID" value="1455"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9BH77"/>
<dbReference type="GO" id="GO:0000166">
<property type="term" value="F:nucleotide binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.720">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016040">
<property type="entry name" value="NAD(P)-bd_dom"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002" evidence="1 2">3D-structure</keyword>
<keyword id="KW-0520" evidence="1 2">NAD</keyword>
<keyword id="KW-0547" evidence="1 2">Nucleotide-binding</keyword>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="216"/>
<end position="218"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="1 2 3">
<location>
<begin position="313"/>
<end position="319"/>
</location>
</feature>
<feature type="binding site" description="NAD; via amide nitrogen" evidence="1 2 3">
<location>
<position position="111"/>
</location>
</feature>
<feature type="binding site" description="NAD" evidence="1 2 3">
<location>
<position position="131"/>
</location>
</feature>
<feature type="binding site" description="NAD" evidence="1 2 3">
<location>
<position position="285"/>
</location>
</feature>
<feature type="non-terminal residue" evidence="9">
<location>
<position position="432"/>
</location>
</feature>
<evidence key="1" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1NHG"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1NHW"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1NNU"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000213">
<source>
<dbReference type="PDB" id="1ZW1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000213">
<source>
<dbReference type="PDB" id="2NQ8"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000213">
<source>
<dbReference type="PDB" id="2OP0"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000213">
<source>
<dbReference type="PDB" id="2OP1"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000313">
<source>
<dbReference type="EMBL" id="AAK25802.1"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000313">
<source>
<dbReference type="EMBL" id="AAK38273.1"/>
</source>
</evidence>
<sequence length="432" mass="49820" checksum="6805B1E3D31D7AA2" modified="2001-06-01" version="1">
MNKISQRLLFLFLHFYTIVCFIQNNTQKTFHNVLHNEQIRGKEKAFYRKEKRENIFIGNK
MKHLNNMNNTHNNNHYMEKEEQDASNIYKIKEENKNEDICFIAGIGDTNGYGWGIAKELS
KRNVKIIFGIWPPVYNIFMKNYKNGKFDNDMIIDKDKKMNILDMLPFDASFDTANDIDEE
TKNNKRYNMLQNYTIEDVANLIHQKYGKINMLVHSLANAKEVQKDLLNTSRKGYLDALSK
SSYSLISLCKYFVNIMKPQSSIISLTYHASQKVVPGYGGGMSSAKAALESDTRVLAYHLG
RNYNIRINTISAGPLKSRAATAINKLNNTYENNTNQNKNRNSHDVHNIMNNSGEKEEKKN
SASQNYTFIDYAIEYSEKYAPLRQKLLSTDIGSVASFLLSRESRAITGQTIYVDNGLNIM
FLPDDIYRNENE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>